GRACEcast

Immunotherapy for Squamous Non-Small Cell Lung Cancer


Listen Later

Research released at the 2015 American Society of Clinical Oncology (ASCO) annual meeting showed great promise for squamous cell lung cancer patients taking the immunotherapy drug Opdivo (nivolumab). But can we predict which patients will do well on it?

...more
View all episodesView all episodes
Download on the App Store

GRACEcastBy Howard (Jack) West, MD